Literature DB >> 16837178

Structure-permeation relationships for the non-invasive transdermal delivery of cationic peptides by iontophoresis.

Yannic B Schuetz1, Pierre-Alain Carrupt, Aarti Naik, Richard H Guy, Yogeshvar N Kalia.   

Abstract

Transdermal iontophoresis enables the controlled, non-invasive administration of peptide therapeutics. The aims of this study were (i) to evaluate the effect of amino acid sequence and the spatial distribution of peptide physicochemical properties on electrotransport, and (ii) to develop a quantitative model to predict peptide transport rates. Experimental results showed that the distribution of molecular properties over the peptide surface significantly affected iontophoretic delivery: different arrangements of the same residues resulted in different transport behavior. Computational studies generated three-dimensional quantitative structure-permeation relationships (3D-QSPR) based on 3D descriptors. The model predicted that iontophoresis was favored by peptide hydrophilicity but hindered by voluminous, localized hydrophobicity. Molecular characteristics that favor electrotransport are the converse of those required for passive diffusion across biological membranes. The data represent the first analysis of peptide electrotransport in terms of the spatial distribution of molecular properties and provide insight into the ab initio prediction of transdermal iontophoretic peptide delivery.

Mesh:

Substances:

Year:  2006        PMID: 16837178     DOI: 10.1016/j.ejps.2006.05.012

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  2 in total

1.  Structure-skin permeability relationship of dendrimers.

Authors:  Venkata Vamsi Venuganti; Preety Sahdev; Michael Hildreth; Xiangming Guan; Omathanu Perumal
Journal:  Pharm Res       Date:  2011-06-02       Impact factor: 4.200

2.  Transdermal delivery of cytochrome C--A 12.4 kDa protein--across intact skin by constant-current iontophoresis.

Authors:  J Cázares-Delgadillo; A Naik; A Ganem-Rondero; D Quintanar-Guerrero; Y N Kalia
Journal:  Pharm Res       Date:  2007-04-25       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.